Novo Nordisk (Denmark) Price on May 8, 2023

NOVO-B Stock  DKK 780.00  2.30  0.29%   
If you're considering investing in Novo Stock, it is important to understand the factors that can impact its price. As of today, the current price of Novo Nordisk stands at 780.00, as last reported on the 4th of December, with the highest price reaching 786.30 and the lowest price hitting 767.90 during the day. Novo Nordisk AS has Sharpe Ratio of -0.0878, which conveys that the firm had a -0.0878% return per unit of risk over the last 3 months. Novo Nordisk exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novo Nordisk's Standard Deviation of 1.97, mean deviation of 1.54, and Risk Adjusted Performance of (0.09) to check out the risk estimate we provide.
  
Novo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0878

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNOVO-B

Estimated Market Risk

 1.95
  actual daily
17
83% of assets are more volatile

Expected Return

 -0.17
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.09
  actual daily
0
Most of other assets perform better
Based on monthly moving average Novo Nordisk is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novo Nordisk by adding Novo Nordisk to a well-diversified portfolio.

Novo Nordisk Valuation on May 8, 2023

It is possible to determine the worth of Novo Nordisk on a given historical date. On May 8, 2023 Novo was worth 549.18 at the beginning of the trading date compared to the closed value of 564.04. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Novo Nordisk stock. Still, in general, we apply an absolute valuation method to find Novo Nordisk's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Novo Nordisk where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Novo Nordisk's related companies.
 Open High Low Close Volume
  516.79    539.73    516.79    538.45    6,639,812  
05/08/2023
  549.18    569.65    546.52    564.04    4,348,940  
  564.83    564.83    550.75    561.98    2,856,012  
Backtest Novo Nordisk  |  Novo Nordisk History  |  Novo Nordisk Valuation   PreviousNext  
Open Value
549.18
543.34
Downside
564.04
Closing Value
555.02
Upside

Novo Nordisk Trading Date Momentum on May 8, 2023

On May 09 2023 Novo Nordisk AS was traded for  561.98  at the closing time. The highest price during the trading period was 564.83  and the lowest recorded bid was listed for  550.75 . The volume for the day was 2.9 M. This history from May 9, 2023 contributed to the next trading day price decline. The trading delta at closing time to the next closing price was 0.37% . The trading delta at closing time to the current price is 3.28% .

Novo Nordisk AS Fundamentals Correlations and Trends

By evaluating Novo Nordisk's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Novo Nordisk's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Novo financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Novo Nordisk Stock history

Novo Nordisk investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novo Nordisk AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novo Nordisk stock prices may prove useful in developing a viable investing in Novo Nordisk
Novo Nordisk AS, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Novo Nordisk operates under Pharmaceuticals And Biosciences classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 45971 people.

Novo Nordisk Stock Technical Analysis

Novo Nordisk technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Novo Nordisk technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Novo Nordisk trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Novo Nordisk Period Price Range

Low
December 4, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Novo Nordisk AS cannot be verified against its exchange. Please verify the symbol is currently traded on Copenhagen Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Novo Nordisk December 4, 2024 Market Strength

Market strength indicators help investors to evaluate how Novo Nordisk stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novo Nordisk shares will generate the highest return on investment. By undertsting and applying Novo Nordisk stock market strength indicators, traders can identify Novo Nordisk AS entry and exit signals to maximize returns

Novo Nordisk Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Novo Nordisk's price direction in advance. Along with the technical and fundamental analysis of Novo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Novo Stock analysis

When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Directory
Find actively traded commodities issued by global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
CEOs Directory
Screen CEOs from public companies around the world